Nachrichten zur Johnson & Johnson Aktie

Global Burn Care Market Size To Worth USD 4.88 Billion By 2033 | CAGR Of 7.3%

The Global Burn Care Market Size was Valued at USD 2.41 Billion in 2023 and the Worldwide Burn Care Market…

Nestlé-Werk Biessenhofen investiert Millionenbetrag in neue Wärmepumpe und reduziert CO2

Frankfurt am Main (ots) - Nestlé spart im Werk Biessenhofen bei der Produktion von Säuglingsnahrung Energie und CO2 ein. Das…

Nestlé-Werk Biessenhofen investiert Millionenbetrag in neue Wärmepumpe und reduziert CO2

Nestlé Deutschland AG: Frankfurt am Main (ots) - Nestlé spart im Werk Biessenhofen bei der Produktion von Säuglingsnahrung Energie und…

Is Johnson & Johnson the Best Dividend Stock for You?

You wont find a more dependable dividend payer on Wall Street. But whether its the best stock for you depends…

Is Johnson & Johnson the Best Dividend Stock for You?

…

JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab

The Johnson & Johnson filing seeks the FDAs approval for nipocalimab to treat generalized myasthenia gravis in a broad population…

Johnson Controls: Strategic Flywheel Gaining Momentum

…

Is Johnson & Johnson Stock a Buy?

The company hasnt performed well in recent years,…

Johnson & Johnson: The Dividend King Is Back

…

J&J (JNJ) to Boost MedTech Business With V-Wave Acquisition

Johnson & Johnson (JNJ) inks a definitive agreement to acquire V-Wave Ltd. for an upfront payment of $600 million. The…

Nerdys (NRDY) VTS Partners With Johnson County Schools

Nerdys (NRDY) leading tutoring services provider partners with Johnson County Schools to offer free access to the VTS platform to…

Johnson & Johnson to acquire V-Wave in deal worth up to $1.1bn By Investing.com

Johnson & Johnson to acquire V-Wave in deal worth up to $1.1bn…

Johnson & Johnson gets green light for lung cancer combination treatment By Investing.com

Johnson & Johnson gets green light for lung cancer combination treatment…

HistoSonics: Überzeichnete Serie D-Finanzierung von $102 Millionen zur Markteinführung von nicht-invasiver Histotripsie-Plattform

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, Hersteller des Edison ® Histotripsie-Systems und neuer Histotripsie-Therapie-Plattformen, hat heute die Beendigung einer überzeichneten Serie-D-Finanzierung von $102 Millionen…

Goldman belässt Astrazeneca auf Buy - Ziel 15756 Pence

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca nach veröffentlichten Fachartikeln für die anstehende…

Analyst Report: Johnson Controls Intl pl

…

J&Js (JNJ) DePuy Synthes TriLEAP System to Aid Ankle Surgery

Johnson & Johnsons (JNJ) DePuy Synthes announces the launch of its TriLEAP System, which is likely to provide better orthopedic…

Johnson Outdoors Inc. (JOUT) Q3 2024 Earnings Call Transcript

…

Johnson Outdoors Reports Fiscal Third Quarter Results

RACINE, Wis., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…

The Markets Excessive Recession Fears

We comment on the ongoing market sell-off, in addition to featuring new research reports on Johnson & Johnson (JNJ), T-Mobile…

Invest $50K in Johnson & Johnson to Become a Dividend Millionaire in 10 Years

…

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

These two healthcare companies have far more upside potential than Johnson & Johnson.…

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now @themotleyfool #stocks $VRTX $JNJ $ISRG

These two healthcare companies have far more upside potential than Johnson & Johnson.…

Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth

Abbott Laboratories growth rate may look comparable to Johnson & Johnsons, but in the long run it could become much…

Führungswechsel bei Johnson & Johnson: Urs Vögeli ist neuer Managing Director

Janssen-Cilag GmbH: Neuss (ots) - Urs Vögeli ist seit dem 1. August 2024 Vorsitzender der Geschäftsführung der Janssen-Cilag GmbH, dem…

United States Pain Management Therapeutics Market Research 2024-2032 Featuring Eli Lilly and Co, Pfizer,. GSK,c Novartis, Merck & Co, Abbott Laboratories, Johnson & Johnson, & Baxter

Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices…

Johnson Controls CEO to retire after constructive conversations with activist Elliott; shares surge

George Olivers retirement is the latest CEO change prompted by activist Elliotts involvement, and comes after the HVAC giant sold…

Johnson Controls CEO to retire, names new director after talks with Elliott By Reuters

Johnson Controls CEO to retire, names new director after talks with Elliott…

Johnson Controls (JCI) Q3 Earnings Top, Revenues Lag Estimates

Johnson Controls (JCI) fiscal third-quarter results benefit from strength in the HVAC & controls businesses.…

Global Battery Technology Market Size To Worth USD 192.86 Billion By 2033 | CAGR Of 6.36%

The Global Battery Technology Market Size was Valued at USD 104.12 Billion in 2023 and the Worldwide Battery Technology Market…

If You Invested $1000 In Johnson & Johnson Stock 20 Years Ago, How Much Would You Have Now?

…

Global Regenerative Medicine Market Size To Worth USD 349.93 Billion By 2033 | CAGR of 27.06%

The Global Regenerative Medicine Market Size was Valued at USD 31.90 Billion in 2023 and the Worldwide Regenerative Medicine Market…

What to Note Ahead of Johnson Controls (JCI) Q3 Earnings?

Johnson Controls (JCI) fiscal Q3 results are likely to benefit from continued improvement in the HVAC & Controls business.…

Could Johnson & Johnsons Troubles With Talc Lawsuits Finally Be Coming to an End?

Is it safe to buy Johnson & Johnson stock now?…

Could Johnson & Johnsons Troubles With Talc Lawsuits Finally Be Coming to an End? @themotleyfool #stocks $JNJ

Is it safe to buy Johnson & Johnson stock now?…

US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold Agglutinin Disease

With few treatment options for patients, hematologists look to pipeline agents such as Johnson & Johnson’s nipocalimab and Novartis’ ianalumab…

Johnson & Johnson: Downgrade

Tokio (www.aktiencheck.de) - Rating-Update: Narumi Nakagiri, Analystin von Daiwa Capital Markets, stuft die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…

Johnson Controls: HVAC Divestment Is Here, Raises Some Questions

…

4 Positives For Johnson & Johnson

…

Johnson & Johnson senkt wegen Kosten für Zukäufe Gewinnprognose

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson (J&J) hat wegen Kosten…

J&J erhöht Vergleichssumme für Babypuder-Krebsklagen erneut

NEW BRUNSWICK (dpa-AFX) - Der US-Pharmakonzern Johnson & Johnson (J&J) will sich weiterhin mit Klägern…

Johnson & Johnson macht Milliardengewinn - Prognosen eingegrenzt

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson (J&J) hat im ersten…

Milliardendeal: Johnson & Johnson will US-Gerätehersteller Shockwave kaufen

NEW BRUNSWICK/SANTA CLARA (dpa-AFX) - Der US-Pharma- und Medizintechnikkonzern Johnson & Johnson will den Hersteller…

Johnson & Johnson verdient 2023 mehr - Schlussquartal unerwartet stark

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnik-Konzern Johnson & Johnson (J&J) hat 2023 von…

WDH/Nachahmerkonkurrenz: Johnson & Johnson rechnet mit weniger Wachstum

(Tippfehler in der Überschrift behoben) NEW BRUNSWICK (dpa-AFX) - Wegen zunehmender Generika-Konkurrenz für…

Nahmahmerkonkurrenz: Johnson & Johnson rechnet mit weniger Wachstum

NEW BRUNSWICK (dpa-AFX) - Wegen zunehmender Generika-Konkurrenz für einen seiner wichtigsten Kassenschlager rechnet der Arzneimittelhersteller Johnson…

Johnson & Johnson übernimmt Medizintechnikspezialist Laminar - Ziele angepasst

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson übernimmt den bisher privat…

Johnson & Johnson wird erneut zuversichtlicher

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson hebt nach einem unerwartet…

Nach Trennung von Konsumgütersparte: Johnson & Johnson fasst Jahresziele neu

NEW BRUNSWICK (dpa-AFX) - Nach Trennung seines Konsumgütergeschäftes hat der Pharma- und Medizintechnikkonzern Johnson & Johnson…

Johnson & Johnson wird erneut optimistischer - Medizintechnik floriert

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Konsumgüterkonzern Johnson & Johnson hebt nach einem unerwartet…

dpa-AFX ProFeed